Avalo Therapeutics Announces The Payoff Of The Remainder Of Its $35M Debt Owed To Horizon Technology Finance
Portfolio Pulse from Benzinga Newsdesk
Avalo Therapeutics has announced the payoff of the remainder of its $35M debt owed to Horizon Technology Finance.
September 26, 2023 | 11:09 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Horizon Technology Finance has received the payoff of the remaining $35M debt from Avalo Therapeutics.
While the payoff of the debt increases Horizon's cash inflow, it also means an end to the interest income from this particular debt. The net effect on Horizon's stock price is uncertain in the short term.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Avalo Therapeutics has paid off its remaining $35M debt to Horizon Technology Finance, which could improve its financial stability.
Paying off debt can improve a company's financial health and stability, which can be seen as a positive sign by investors. This could potentially lead to an increase in the stock price of Avalo Therapeutics in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100